Decoy Therapeutics Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
532K
on 2026-06-30 10-Q ↗
Counts before 2026-06-30 are left out: the count went from 35.1M on 2026-03-31 to 532K on 2026-06-30, a change no split on file explains.
a raise that quarter, at its price
$2.6M
Ladenburg Thalmann, agreement of 2025-08-22. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Cash
4 quarters
$8.3M on 2026-06-30 ÷ $2.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-29 | Private placement | 592,217 | $5.91 | $3.5M | 8-K ↗ |
| 2025-11-12 | Public offering incl. 2.15M pre-funded, with warrants at $2.33 | 4,666,666 | $1.50 | $7.0M | 424B4 ↗ |
| 2025-07-31 | Private placement | not read | not read | $3.8M | 8-K ↗ |
| 2025-01-13 | Private placement | 141,000 | not read | $494K | 8-K ↗ |
Also on file: a 1-for-15 reverse split, 2025-08-15 8-K ↗ · a 1-for-12 reverse split, 2026-03-09 8-K ↗